Literature DB >> 11184232

Assumed versus approved breakpoints.

D A Preston, M R Turnak.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 11184232      PMCID： PMC101647          DOI： 10.1128/AAC.44.11.3243-3245.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  17 in total

1.  New species-related MIC breakpoints for early detection of development of resistance among gram-negative bacteria in Swedish intensive care units.

Authors:  H Hanberger; L E Nilsson; B Claesson; A Kärnell; P Larsson; M Rylander; E Svensson; M Sörberg; L Sörén
Journal:  J Antimicrob Chemother       Date:  1999-11       Impact factor: 5.790

Review 2.  Pharmacokinetics and pharmacodynamics of antibiotics in otitis media.

Authors:  W A Craig; D Andes
Journal:  Pediatr Infect Dis J       Date:  1996-03       Impact factor: 2.129

3.  Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media?

Authors:  R Dagan; O Abramson; E Leibovitz; D Greenberg; R Lang; S Goshen; P Yagupsky; A Leiberman; D M Fliss
Journal:  J Infect Dis       Date:  1997-11       Impact factor: 5.226

4.  Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model.

Authors:  B Vogelman; S Gudmundsson; J Leggett; J Turnidge; S Ebert; W A Craig
Journal:  J Infect Dis       Date:  1988-10       Impact factor: 5.226

Review 5.  Microbiologic efficacy of antibacterial drugs for acute otitis media.

Authors:  J O Klein
Journal:  Pediatr Infect Dis J       Date:  1993-12       Impact factor: 2.129

6.  Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis.

Authors:  E O Mason; L B Lamberth; N L Kershaw; B L Prosser; A Zoe; P G Ambrose
Journal:  J Antimicrob Chemother       Date:  2000-05       Impact factor: 5.790

Review 7.  Evidence-based medicine: empiric antibiotic therapy in community-acquired pneumonia.

Authors:  R C Read
Journal:  J Infect       Date:  1999-11       Impact factor: 6.072

Review 8.  Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

Authors:  W A Craig
Journal:  Clin Infect Dis       Date:  1998-01       Impact factor: 9.079

9.  New insight into the clinical pharmacokinetics of cefaclor: tissue penetration.

Authors:  T Mazzei; A Novelli; S Esposito; P Periti
Journal:  J Chemother       Date:  2000-02       Impact factor: 1.714

10.  Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon".

Authors:  C D Marchant; S A Carlin; C E Johnson; P A Shurin
Journal:  J Pediatr       Date:  1992-01       Impact factor: 4.406
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.